» Articles » PMID: 17626127

Interaction Between Myosin Heavy Chain and Troponin Isoforms Modulate Cardiac Myofiber Contractile Dynamics

Overview
Specialty Physiology
Date 2007 Jul 13
PMID 17626127
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Coordinated expression of species-specific myosin heavy chain (MHC) and troponin (Tn) isoforms may bring about a dynamic complementarity to match muscle contraction speed with species-specific heart rates. Contractile system function and dynamic force-length measurements were made in muscle fibers from mouse and rat hearts and in muscle fibers after reconstitution with either recombinant homologous Tn or orthologous Tn. The rate constants of length-mediated cross-bridge (XB) recruitment (b) and tension redevelopment (k(tr)) of mouse fibers were significantly faster than those of rat fibers. Both the tension cost (ATPase/tension) and rate constant of length-mediated XB distortion (c) were higher in the mouse than in the rat. Thus the mouse fiber was faster in all dynamic and functional aspects than the rat fiber. Mouse Tn significantly increased b and k(tr) in rat fibers; conversely, rat Tn significantly decreased b and k(tr) in mouse fibers. Thus the length-mediated recruitment of force-bearing XB occurs much more rapidly in the presence of mouse Tn than in the presence of rat Tn, demonstrating that the speed of XB recruitment is regulated by Tn. There was a significant interaction between Tn and MHC such that changes in either Tn or MHC affected the speed of XB recruitment. Our data demonstrate that the dynamics of myocardial contraction are different in the mouse and rat hearts because of sequence heterogeneity in MHC and Tn. At the myofilament level, coordinated expression of complementary regulatory contractile proteins produces a functional dynamic phenotype that allows the cardiovascular systems to function effectively at different heart rates.

Citing Articles

The role of the M-band myomesin proteins in muscle integrity and cardiac disease.

Lamber E, Guicheney P, Pinotsis N J Biomed Sci. 2022; 29(1):18.

PMID: 35255917 PMC: 8900313. DOI: 10.1186/s12929-022-00801-6.


Preventative therapeutic approaches for hypertrophic cardiomyopathy.

Solomon T, Filipovska A, Hool L, Viola H J Physiol. 2020; 599(14):3495-3512.

PMID: 32822065 PMC: 8359240. DOI: 10.1113/JP279410.


Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.

Clippinger S, Cloonan P, Greenberg L, Ernst M, Stump W, Greenberg M Proc Natl Acad Sci U S A. 2019; 116(36):17831-17840.

PMID: 31427533 PMC: 6731759. DOI: 10.1073/pnas.1910962116.


Sarcomere length-dependent effects on Ca-troponin regulation in myocardium expressing compliant titin.

Li K, Methawasin M, Tanner B, Granzier H, Solaro R, Dong W J Gen Physiol. 2018; 151(1):30-41.

PMID: 30523116 PMC: 6314383. DOI: 10.1085/jgp.201812218.


Role of the C-terminus mobile domain of cardiac troponin I in the regulation of thin filament activation in skinned papillary muscle strips.

Bohlooli Ghashghaee N, Li K, Solaro R, Dong W Arch Biochem Biophys. 2018; 648:27-35.

PMID: 29704484 PMC: 5977403. DOI: 10.1016/j.abb.2018.04.014.